Valuation: Baxter International Inc.

Market Cap 11.68B 10.22B 9.43B 8.71B 16.52B 1,114B 16.8B 113B 44.23B 549B 43.86B 42.91B 1,887B P/E 2026 *
52.2x
P/E 2027 * 28.7x
Enterprise Value 18.16B 15.89B 14.65B 13.53B 25.68B 1,732B 26.11B 175B 68.75B 853B 68.19B 66.71B 2,933B EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.53x
Free-Float
75.3%
Yield 2026 *
0.18%
Yield 2027 * 0.18%
1 day+0.71%
1 week-0.13%
Current month+6.10%
1 month+8.44%
3 months+31.90%
6 months+12.26%
Current year+18.37%
1 week 21.73
Extreme 21.73
23.52
1 month 19.38
Extreme 19.38
23.52
Current year 15.73
Extreme 15.73
23.52
1 year 15.73
Extreme 15.73
29.35
3 years 15.73
Extreme 15.73
50.21
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Director of Finance/CFO 52 2026-03-15
Chief Tech/Sci/R&D Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap.
Jun. 01Tax

President, Adv. Surgery

-153 0.0000%
Jun. 01Tax

President, CCS

-321 0.0001%
May. 31Free

Chief Financial Officer

13,426 0.0026%
Change 5-day change 1-year change 3-year change Capi.($)
+0.71%-0.13%-21.18%-51.23% 11.68B
-0.50%-1.54%-28.85%-12.09% 164B
+1.80%+0.82%-6.73%-4.23% 107B
+0.32%+2.34%+2.79%+59.04% 59.04B
+2.02%-0.37%+40.23%+55.65% 51.72B
+0.72%-3.88%-13.66%-41.26% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-43.92% 28.93B
-1.10%-3.29%+55.70%-7.77% 24.99B
0.00%-1.01%-5.28%-4.72% 21.05B
Average +0.71%-1.01%+1.44%-5.61% 54.49B
Weighted average by Cap. +0.62%-0.93%-5.93%+0.08%

Financials

2026 *2027 *
Net sales 11.36B 9.94B 9.16B 8.46B 16.06B 1,083B 16.33B 110B 43B 534B 42.65B 41.72B 1,835B 11.58B 10.13B 9.34B 8.63B 16.38B 1,105B 16.65B 112B 43.85B 544B 43.49B 42.54B 1,871B
Net income 218M 191M 176M 163M 309M 20.84B 314M 2.11B 827M 10.27B 820M 803M 35.29B 397M 347M 321M 296M 562M 37.89B 571M 3.83B 1.5B 18.67B 1.49B 1.46B 64.17B
Net Debt 6.48B 5.67B 5.23B 4.83B 9.16B 618B 9.31B 62.46B 24.53B 304B 24.33B 23.8B 1,046B 6.01B 5.25B 4.85B 4.48B 8.49B 573B 8.64B 57.91B 22.74B 282B 22.56B 22.07B 970B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-07-10 $22.62 +0.71% 3,103,103
26-07-09 $22.46 +2.18% 4,063,730
26-07-08 $21.98 -3.85% 6,788,762
26-07-07 $22.86 +1.24% 5,990,911
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
22.62USD
Average target price
21.71USD
Spread / Average Target
-4.03%

Quarterly revenue - Rate of surprise